685 related articles for article (PubMed ID: 18383312)
1. Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR).
Chao EC; Velasquez JL; Witherspoon MS; Rozek LS; Peel D; Ng P; Gruber SB; Watson P; Rennert G; Anton-Culver H; Lynch H; Lipkin SM
Hum Mutat; 2008 Jun; 29(6):852-60. PubMed ID: 18383312
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
[TBL] [Abstract][Full Text] [Related]
3. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
[TBL] [Abstract][Full Text] [Related]
4. Calibration of multiple in silico tools for predicting pathogenicity of mismatch repair gene missense substitutions.
Thompson BA; Greenblatt MS; Vallee MP; Herkert JC; Tessereau C; Young EL; Adzhubey IA; Li B; Bell R; Feng B; Mooney SD; Radivojac P; Sunyaev SR; Frebourg T; Hofstra RM; Sijmons RH; Boucher K; Thomas A; Goldgar DE; Spurdle AB; Tavtigian SV
Hum Mutat; 2013 Jan; 34(1):255-65. PubMed ID: 22949387
[TBL] [Abstract][Full Text] [Related]
5. Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein.
Ollila S; Sarantaus L; Kariola R; Chan P; Hampel H; Holinski-Feder E; Macrae F; Kohonen-Corish M; Gerdes AM; Peltomäki P; Mangold E; de la Chapelle A; Greenblatt M; Nyström M
Gastroenterology; 2006 Nov; 131(5):1408-17. PubMed ID: 17101317
[TBL] [Abstract][Full Text] [Related]
6. Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome.
Gargiulo S; Torrini M; Ollila S; Nasti S; Pastorino L; Cusano R; Bonelli L; Battistuzzi L; Mastracci L; Bruno W; Savarino V; Sciallero S; Borgonovo G; Nyström M; Bianchi-Scarrà G; Mareni C; Ghiorzo P
Fam Cancer; 2009; 8(4):547-53. PubMed ID: 19728162
[TBL] [Abstract][Full Text] [Related]
7. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.
Skeldon SC; Semotiuk K; Aronson M; Holter S; Gallinger S; Pollett A; Kuk C; van Rhijn B; Bostrom P; Cohen Z; Fleshner NE; Jewett MA; Hanna S; Shariat SF; Van Der Kwast TH; Evans A; Catto J; Bapat B; Zlotta AR
Eur Urol; 2013 Feb; 63(2):379-85. PubMed ID: 22883484
[TBL] [Abstract][Full Text] [Related]
8. Analysis of mismatch repair gene mutations in Turkish HNPCC patients.
Tunca B; Pedroni M; Cecener G; Egeli U; Borsi E; Zorluoglu A; Di Gregorio C; Yilmazlar T; Yerci O; de Leon MP
Fam Cancer; 2010 Sep; 9(3):365-76. PubMed ID: 20373145
[TBL] [Abstract][Full Text] [Related]
9. Frequent mismatch-repair defects link prostate cancer to Lynch syndrome.
Dominguez-Valentin M; Joost P; Therkildsen C; Jonsson M; Rambech E; Nilbert M
BMC Urol; 2016 Mar; 16():15. PubMed ID: 27013479
[TBL] [Abstract][Full Text] [Related]
10. Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features.
Belvederesi L; Bianchi F; Loretelli C; Gagliardini D; Galizia E; Bracci R; Rosati S; Bearzi I; Viel A; Cellerino R; Porfiri E
Eur J Hum Genet; 2006 Jul; 14(7):853-9. PubMed ID: 16724012
[TBL] [Abstract][Full Text] [Related]
11. Validation microsatellite path score in a population-based cohort of patients with colorectal cancer.
Bessa X; Alenda C; Paya A; Álvarez C; Iglesias M; Seoane A; Dedeu JM; Abulí A; Ilzarbe L; Navarro G; Pellise M; Balaguer F; Castellvi-Bel S; Llor X; Castells A; Jover R; Andreu M
J Clin Oncol; 2011 Sep; 29(25):3374-80. PubMed ID: 21788563
[TBL] [Abstract][Full Text] [Related]
12. Evidence for breast cancer as an integral part of Lynch syndrome.
Buerki N; Gautier L; Kovac M; Marra G; Buser M; Mueller H; Heinimann K
Genes Chromosomes Cancer; 2012 Jan; 51(1):83-91. PubMed ID: 22034109
[TBL] [Abstract][Full Text] [Related]
13. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations.
Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK
Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128
[TBL] [Abstract][Full Text] [Related]
14. Prediction of MLH1 and MSH2 mutations in Lynch syndrome.
Balmaña J; Stockwell DH; Steyerberg EW; Stoffel EM; Deffenbaugh AM; Reid JE; Ward B; Scholl T; Hendrickson B; Tazelaar J; Burbidge LA; Syngal S
JAMA; 2006 Sep; 296(12):1469-78. PubMed ID: 17003395
[TBL] [Abstract][Full Text] [Related]
15. Multiplex SNaPshot genotyping for detecting loss of heterozygosity in the mismatch-repair genes MLH1 and MSH2 in microsatellite-unstable tumors.
Bujalkova M; Zavodna K; Krivulcik T; Ilencikova D; Wolf B; Kovac M; Karner-Hanusch J; Heinimann K; Marra G; Jiricny J; Bartosova Z
Clin Chem; 2008 Nov; 54(11):1844-54. PubMed ID: 18772310
[TBL] [Abstract][Full Text] [Related]
16. A review of mismatch repair gene transcripts: issues for interpretation of mRNA splicing assays.
Thompson BA; Martins A; Spurdle AB
Clin Genet; 2015 Feb; 87(2):100-8. PubMed ID: 24989436
[TBL] [Abstract][Full Text] [Related]
17. UMD-MLH1/MSH2/MSH6 databases: description and analysis of genetic variations in French Lynch syndrome families.
Grandval P; Fabre AJ; Gaildrat P; Baert-Desurmont S; Buisine MP; Ferrari A; Wang Q; Béroud C; Olschwang S
Database (Oxford); 2013; 2013():bat036. PubMed ID: 23729658
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the effect of unclassified variants identified in MMR genes using phenotypic features, bioinformatics prediction, and RNA assays.
Pérez-Cabornero L; Infante M; Velasco E; Lastra E; Miner C; Durán M
J Mol Diagn; 2013 May; 15(3):380-90. PubMed ID: 23523604
[TBL] [Abstract][Full Text] [Related]
19. CHEK2 mutations and HNPCC-related colorectal cancer.
Suchy J; Cybulski C; Wokołorczyk D; Oszurek O; Górski B; Debniak T; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dziuba I; Gogacz M; Wiśniowski R; Wandzel P; Banaszkiewicz Z; Kurzawski G; Kładny J; Narod SA; Lubiński J
Int J Cancer; 2010 Jun; 126(12):3005-9. PubMed ID: 19876921
[TBL] [Abstract][Full Text] [Related]
20. Novel approaches in evaluation of pathogenicity of single-base exonic germline changes involving the mismatch repair genes MLH1 and MSH2 in diagnostics of Lynch syndrome.
Gerykova-Bujalkova M; Krivulcik T; Bartosova Z
Neoplasma; 2008; 55(6):463-71. PubMed ID: 18999873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
